During the past decade, Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE" #1 sponsor was "Conde, Bebiana, M.D." with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Dicerna Pharmaceuticals, Inc." with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Everest Medicines" with 1 trials as a collaborator, "Haukeland University Hospital" with 1 trials as a collaborator and "Paris 12 Val de Marne University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE" are "Amyotrophic Lateral Sclerosis" (2 trials), "Urinary Bladder Neoplasms" (2 trials), "Acute Respiratory Failure" (1 trials), "Alpha 1-Antitrypsin Deficiency" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE" in a lesser frequency.

Most popular intervention types in "Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE" are "Drug" (9 trials), "Biological" (5 trials), "Other" (4 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetrelimab" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Placebo" (2 trials) and "TAR-200" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".